Ashler et Manson S.A.
€1.27€0.00 (0.0%)
Ashler et Manson S.A.’s quoted price sits in the lower half of its reported 52-week range, 61.28% below the high.
PAR · MLIRF.PA · EUR
Stock price, earnings
Quote as of Sep 9, 2026, 09:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
Innovative-RFK S.p.A.’s quoted price sits in the upper half of its reported 52-week range, 6.25% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Innovative-RFK S.p.A.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Innovative-RFK S.p.A. functions as a private equity and venture capital firm, primarily focused on injecting capital into small and medium-sized enterprises (SMEs). The firm supports companies across their developmental spectrum, from initial start-up phases to emerging and established growth. Beyond direct company investments, it also allocates capital to other private equity funds through a fund-of-funds strategy. Its investment preferences span sectors such as biomedical systems, microcredit solutions for SMEs, information technology, the broader high-tech industry, and innovative solutions applicable across various industries. Geographically, Innovative-RFK predominantly targets companies based in Italy. The firm typically commits up to €3 million (approximately $3.54 million) to companies that demonstrate an enterprise value and sales revenue of up to €50 million (around $58.96 million), with an EBITDA reaching up to €5 million (roughly $5.90 million). These investments are funded directly from its own proprietary capital. Innovative-RFK is flexible in its ownership approach, acquiring either minority or majority equity stakes in its portfolio companies. An Initial Public Offering (IPO) serves as its preferred exit strategy, typically targeted within an ambitious 18 to 24-month timeframe. Innovative-RFK S.p.A. was established in 2017 and is headquartered in Milan, Italy.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:33 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€1.27€0.00 (0.0%)
Ashler et Manson S.A.’s quoted price sits in the lower half of its reported 52-week range, 61.28% below the high.
€0.11-€0.01 (-6.67%)
Crypto Blockchain Industries’s quoted price sits in the lower half of its reported 52-week range, 54.14% below the high.
€41.80€0.00 (0.0%)
Hamilton Global Opportunities PLC’s quoted price sits in the lower half of its reported 52-week range, 5.0% below the high.
€3.56€0.00 (0.0%)
Audacia S.A.’s quoted price sits in the lower half of its reported 52-week range, 44.81% below the high.
€1.90€0.00 (0.0%)
Electricité et Eaux de Madagascar S.A.’s quoted price sits in the lower half of its reported 52-week range, 39.87% below the high.
€13.40€0.00 (0.0%)
Fin.Ouest Africain’s quoted price sits in the lower half of its reported 52-week range, 55.33% below the high.
€0.08€0.00 (0.0%)
Photonike Capital S.A.’s quoted price sits in the lower half of its reported 52-week range, 42.75% below the high.
€64.00€0.00 (0.0%)
Financiere Hoche Bains-Les-Bains S.A.’s quoted price sits in the lower half of its reported 52-week range, 24.26% below the high.